Alzheimer's medication Reminyl XL/Razadyne (galantamine hydrobromide) from Janssen Pharma, appears to slash inflammation and insulin resistance in patients with metabolic...
A new study shows a significantly lower mortality rate in patients with mild to moderately severe Alzheimer's disease who were...
A Phase II/III clinical trial evaluating Athira Pharma’s experimental therapy fosgonimeton (formerly ATH-1017) in people with mild to moderate Alzheimer’s disease should continue as planned